首页 | 本学科首页   官方微博 | 高级检索  
     

万拉法新与帕罗西汀治疗抑郁症的临床对照研究
引用本文:过秋燕,冯尔越,任宏泉. 万拉法新与帕罗西汀治疗抑郁症的临床对照研究[J]. 中国民康医学, 2002, 14(6): 354-355
作者姓名:过秋燕  冯尔越  任宏泉
作者单位:214035,江苏省荣军医院
摘    要:目的 :比较万拉法新和帕罗西汀治疗抑郁症的疗效和副作用。方法 :将符合CCMD 2 R抑郁症诊断标准的患者随机分成两组 ,分别予万拉法新和帕罗西汀治疗 ,观察时间为四周。用汉密尔顿(HAMD)抑郁量表减分率评定疗效。不良反应症状量表 (TESS)评定副作用。结果 :两组显效率分别为80 9%和 79 4 % ,疗效及副反应无显著差异。结论 :万拉法新与帕罗西汀疗效较好 ,较安全的抗抑郁药物。

关 键 词:万拉法新  帕罗西汀  抑郁症
文章编号:1002-4719(2002)06-0354-02
修稿时间:2002-09-21

A clinical control study of venlafaxine and paroxetine in the treatment of depression
Gou qiu yian,Feng er yue,Ren hong quan,Rongjun Hospital of Jiangsu. A clinical control study of venlafaxine and paroxetine in the treatment of depression[J]. medical journal of chinese peoples health, 2002, 14(6): 354-355
Authors:Gou qiu yian  Feng er yue  Ren hong quan  Rongjun Hospital of Jiangsu
Affiliation:Gou qiu yian,Feng er yue,Ren hong quan,Rongjun Hospital of Jiangsu,214035
Abstract:Objective: To compare clinical efficacy and side-effects between venlafaxine and paroxetine in the treatment of depression. Method: The patients who met CCME-2-R for depression were randomly assigned to 2 group was treated with venlafaxine and the other with paroxetine for four weeks. Hamiltion rating scale, treatment emergent symptom scale were used to assess. Results: Total clinical effective rate was 80.9% for venlafaxine group and 79.4% for paroxetime group. There were no differences in clinical efficacy and side-effects between the two groups. Conclusion: The results indicate that venlafaxine and paroxetine are safe effective drug for the treatment of depression.
Keywords:Venlafaxine Paroxetine Depression
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号